Mission & Scientific Vision
MetaResistome provides an authoritative, interdisciplinary platform for the rapid dissemination of rigorous scientific discoveries addressing one of the most pressing global health challenges of our time: the emergence, evolution, and dissemination of antimicrobial resistance.
MetaResistome emphasizes systems-level investigations that integrate high-throughput sequencing, bioinformatic workflows, molecular epidemiology, and environmental surveillance to decipher the resistome, mobilome, and virulome of clinical and environmental pathogens.
Primary Areas of Scope
- Antimicrobial Resistome Characterization: Identification, molecular profiling, and functional genomics of novel and circulating antibiotic resistance genes (ARGs) across human, animal, and environmental microbiomes.
- Pathogen Genomics & Molecular Epidemiology: Whole-genome sequencing (WGS), comparative genomics, phylodynamics, and surveillance of priority bacterial, viral, and fungal pathogens.
- Wastewater-Based & Environmental Surveillance: Metagenomic wastewater monitoring, sewage epidemiology, environmental reservoirs of resistance, and runoff assessment in urban and agricultural matrices.
- Mobilome & Horizontal Gene Transfer (HGT): Plasmids, transposons, integrons, bacteriophages, and mobile genetic elements mediating the cross-species transfer of multidrug resistance.
- One Health Resistome Dynamics: Interconnected transmission networks linking clinical healthcare settings, veterinary medicine, livestock production, wildlife, and natural ecosystems.
- Bioinformatics, Machine Learning & Computational Biology: Novel algorithmic pipelines, deep learning models for resistance prediction, metagenomic assembly benchmarks, and reference resistome databases.
- Novel Therapeutics & Diagnostics: Next-generation antimicrobials, phage therapy, antimicrobial peptides, and rapid diagnostic platforms for point-of-care pathogen and resistance profiling.
Peer Review Philosophy
All submitted manuscripts undergo single-blind, rigorous peer review by active domain specialists. We prioritize scientific validity, methodological reproducibility, open data availability, and transparent reporting over speculative novelty.